Teva and IBM have formed a three-year, Watson-enabled drug repurposing collaboration

Ginkgo Bioworks has teamed up with Prospect Bio to incorporate biosensors into its organism design process.

Organ-on-a-chip player Emulate has added $17 million to its Series B round and landed a deal with Covance.

A council chaired by President Obama has called for countries to cooperate to investigate the potential uses of artificial intelligence in healthcare.

Amadeus Capital and Jonathan Milner have teamed up to invest in Healx, a startup working with patient advocacy groups to repurpose drugs for rare diseases.

Recursion Pharmaceuticals has raised $12.9 million to scale up its computer-driven approach to drug development.

UC San Francisco has landed $24 million in National Science Foundation funding to set up the Center for Cellular Construction.

British startup BenevolentAI has become the first European firm to install a purpose-built version of the DGX-1, a supercomputer designed for deep learning.